Difference between revisions of "Obinutuzumab (Gazyva)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 15: Line 15:
  
 
==Patient drug information==
 
==Patient drug information==
No information available.
+
*[http://www.gene.com/download/pdf/gazyva_prescribing.pdf Obinutuzumab (Gazyva) package insert]<ref name="insert"></ref>
 +
*[https://chemocare.com/chemotherapy/drug-info/obinutuzumab.aspx Obinutuzumab (Gazyva)patient drug information (Chemocare)]<ref>[https://chemocare.com/chemotherapy/drug-info/obinutuzumab.aspx Obinutuzumab (Gazyva)patient drug information (Chemocare)]</ref>
 +
*[http://www.uptodate.com/contents/obinutuzumab-patient-drug-information Obinutuzumab (Gazyva)patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/obinutuzumab-patient-drug-information Obinutuzumab (Gazyva)patient drug information (UpToDate)]</ref>
  
 
==History of changes in FDA indication==
 
==History of changes in FDA indication==

Revision as of 19:51, 23 July 2022

General information

Class/mechanism: Glyco-engineered anti-CD20 IgG1 type II monoclonal antibody. Engineered with a modified elbow hinge residue (valine instead of leucine at Kabat position 11) and a glyco-engineered Fc region, which is postulated to enhance its immunomodulatory effect.[1][2][3]
Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert.[1]

Diseases for which it is established (work in progress)

Diseases for which it is used

Patient drug information

History of changes in FDA indication

Chronic lymphocytic leukemia

Follicular lymphoma

Also known as

  • Code names: GA101, R7159, RO5072759
  • Generic name: afutuzumab
  • Brand name: Gazyva

References